License Agreement of SGLT2 Inhibitor “CSG452” in Japan

First Page		Document Content
Date: 2012-10-26 01:56:33 Hoffmann-La Roche Pharmaceutical sciences Organic chemistry Sanofi Diabetes management Pharmaceutical industry Diabetes mellitus Pitavastatin SLC5A2 Chemistry Diabetes Chugai Pharmaceutical Co.		License Agreement of SGLT2 Inhibitor “CSG452” in Japan Add to Reading List Source URL: www.kowa.co.jp Download Document from Source Website File Size: 80,72 KB Share Document on Facebook

	Updated45th National Organic Chemistry Symposium University of California, Davis DocID: 1vpb3 - View Document
	Department SAGE (Sciences de l’Atmosphère et Génie de l’Environnement) February 2018 Ph.D. Position in Atmospheric Chemistry Title: Sources and atmospheric impact of shipping activities on organic carbon in Marseil DocID: 1vmII - View Document
	Chapter 1 Review Name ____________________________________ Period _______ Date ________________________ 1. Match the project to the appropriate field of chemistry (inorganic chemistry, organic chemistry, biochemistry, DocID: 1veSt - View Document
	ESR 2 position Project title: Developing the biological potential of organometallic cages PhD Fellowship in Organic synthesis, Bio-organometallic and Medicinal chemistry Location: UNIVERSITE de NEUCHATEL (Neuchâtel, Swi DocID: 1vdMZ - View Document
	Division of Synthetic Chemistry – Synthetic Organic Chemistry – http://www.fos.kuicr.kyoto-u.ac.jp/EnglishTop/English.top.html Prof KAWABATA, Takeo DocID: 1vbNv - View Document